Assessing responses to cancer therapy using molecular imaging.
about
Imaging in the era of molecular oncology.Advances in Molecular Imaging Strategies for In Vivo Tracking of Immune CellsMetabolomic profiling of drug responses in acute myeloid leukaemia cell linesFailure of annexin-based apoptosis imaging in the assessment of antiangiogenic therapy effects.Discovery of a phosphatidylserine-recognizing peptide and its utility in molecular imaging of tumour apoptosisSpecific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.Detecting treatment response in a model of human breast adenocarcinoma using hyperpolarised [1-13C]pyruvate and [1,4-13C2]fumarateImaging and cancer: a review.In vivo molecular imaging of colorectal cancer using quantum dots targeted to vascular endothelial growth factor receptor 2 and optical coherence tomography/laser-induced fluorescence dual-modality imaging.Molecular Magnetic Resonance Imaging of Tumor Response to Therapy.Dual-Modality Optical/PET Imaging of PARP1 in GlioblastomaAssessing the effects of estrogen on the dynamics of breast cancer.Radiation-guided P-selectin antibody targeted to lung cancerNanovehicular intracellular delivery systems.A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatmentUsing optical spectroscopy to longitudinally monitor physiological changes within solid tumors.Advances in quantitative UV-visible spectroscopy for clinical and pre-clinical application in cancer.Quantitative optical spectroscopy can identify long-term local tumor control in irradiated murine head and neck xenografts.In vivo imaging in cancer.Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments.A Nile blue based infrared fluorescent probe: imaging tumors that over-express cyclooxygenase-2.PACE4-based molecular targeting of prostate cancer using an engineered ⁶⁴Cu-radiolabeled peptide inhibitor.Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm.Optical molecular imaging approach for rapid assessment of response of individual cancer cells to chemotherapy.The potential of hyperpolarized 13C magnetic resonance spectroscopy to monitor the effect of combretastatin based vascular disrupting agents.
P2860
Q24650949-B75D5FF0-3BE7-44CE-B748-BA53DDBB3EBAQ28076866-F06909A6-AF96-4BEF-8616-8A9D32519D2BQ28474545-D5715702-AD86-4575-BC37-D9EFA044CCC6Q30470766-641D003D-9693-4007-B51E-21A359F86E89Q33325338-41EDDC10-FEA7-4D52-B3B6-FCF4E6F9AAAFQ34203953-9F56653A-82A8-432A-BD54-3EEDE4A6F2ABQ34344210-BEBF5BA9-DDA2-4418-81B0-C7801B2D9064Q34977050-830A7715-F75C-425D-8F58-BF8E114B7FF8Q35784601-1B50127D-2C79-4DBC-A9AB-BBFFD6FCCF6CQ36123378-FC4DC320-BAE7-410D-91E1-7DA4E37AC56DQ36172457-1A681F93-EAF2-4CA4-8768-996E13836E4AQ36506621-E515991A-92DA-461F-AA0A-3B9FB4FA26B9Q36537700-00E51611-EC07-496B-8BDB-C43BE201B9E3Q37058812-53A72525-C90C-4E02-8961-54757998ACB3Q37200476-9B629B3E-110D-46DC-A862-E7461DA3B717Q37328139-D43A7A19-AD1E-4D64-A70E-F87D92A9C213Q37344219-539902B9-7462-47A1-9EA2-13C940C07832Q37419964-1B3AD110-2171-41D6-8B05-35834849C556Q37791278-719757E1-3E4D-47F1-AB6A-FD8464FD22D5Q37995451-1A2C0870-1820-48F8-8F02-7D12955CDE12Q38937824-24A8BD4A-E0FB-4123-8219-E2AB42A4EC9AQ38956599-D4BD86A4-CB3C-4A1C-830B-F25A37EE9771Q39303314-627A2DCF-AAA1-44BA-985C-E009E9C83590Q42053570-A6D83A25-80A8-427F-8707-EB1B60E1C3C2Q47792667-49FC249A-AD14-49A6-8CF7-81BC1B5DED5C
P2860
Assessing responses to cancer therapy using molecular imaging.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Assessing responses to cancer therapy using molecular imaging.
@ast
Assessing responses to cancer therapy using molecular imaging.
@en
type
label
Assessing responses to cancer therapy using molecular imaging.
@ast
Assessing responses to cancer therapy using molecular imaging.
@en
prefLabel
Assessing responses to cancer therapy using molecular imaging.
@ast
Assessing responses to cancer therapy using molecular imaging.
@en
P1476
Assessing responses to cancer therapy using molecular imaging.
@en
P2093
André A Neves
Kevin M Brindle
P304
P356
10.1016/J.BBCAN.2006.10.002
P407
P577
2006-10-24T00:00:00Z